Filing Details
- Accession Number:
- 0000070858-24-000322
- Form Type:
- 13G Filing
- Publication Date:
- 2024-11-13 19:00:00
- Filed By:
- Bank Of America Corp /de/
- Company:
- Acasti Pharma Inc. (NASDAQ:ACST)
- Filing Date:
- 2024-11-14
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Beneficially Owned Number of Shares | Beneficially Owned Number of Aggregate Shares | Percent of Class |
|---|---|---|---|
| BANK OF AMERICA CORP DE 56-0906609 | 0 | 494,698 | 0 |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No.
01)*
GRACE THERAPEUTICS, INC.
(Name of Issuer)
Common Stock
00439U104
September 30, 2024
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
⌧
Rule 13d-1(b)
□
Rule 13d-1(c)
□
Rule 13d-1(d)
*
The remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
| CUSIP No. | 00439U104 |
| 1 |
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | ||||
| BANK OF AMERICA CORP /DE/ 56-0906609 | |||||
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | ||||
| (a) □ | |||||
| (b) ⌧ | |||||
| 3 | SEC USE ONLY | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
| Delaware | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | SOLE VOTING POWER | |||
| 0 | |||||
| 6 | SHARED VOTING POWER | ||||
| 494,698 | |||||
| 7 | SOLE DISPOSITIVE POWER | ||||
| 0 | |||||
| 8 | SHARED DISPOSITIVE POWER | ||||
| 494,698 | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
| 494,698 | |||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
| □ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
| 4.9 % | |||||
| 12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
| HC | |||||
FOOTNOTES | |||||
| Per 8K filed by the issuer with the SEC on October 28, 2024, Grace Therapeutics, Inc. filed a certificate of amendment to its Certificate of Incorporation with the Secretary of State of Delaware solely to change the name of the company from Acasti Pharma Inc. to Grace Therapeutics, Inc. The name change became effective on October 28, 2024. In addition, on October 8, 2024, the CUSIP of the issuer changed from 00430K865 to 00439U104. This filing is submitted based on the Reporting Person beneficial ownership on CUSIP 00430K865 as of September 30, 2024. | |||||
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and correct.
| BANK OF AMERICA CORP /DE/ | |||
|
Date:
November 14, 2024
|
By:
| /s/ Andres Ortiz | |
| Andres Ortiz | |||
| Title: Authorized Signatory | |||
| Footnotes: |
| Attention: |
Intentional
misstatements or omissions of fact constitute Federal criminal violations (See
18 U.S.C. 1001)
|